本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

再鼎醫藥

28.29
-0.5500-1.91%
盤後28.290.00000.00%16:10 EDT
成交量:94.76萬
成交額:2,678.66萬
市值:31.62億
市盈率:-13.92
高:28.83
開:28.40
低:27.81
收:28.84
52周最高:44.34
52周最低:23.82
股本:1.12億
流通股本:1.10億
量比:1.23
換手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):-2.0329
每股收益(LYR):-2.5984
淨資產收益率:-28.41%
總資產收益率:-14.35%
市淨率:3.99
市盈率(LYR):-10.89

資料載入中...

2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/19

SEC問詢函

Form CORRESP - Correspondence
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities